Presentation and publications #latebreaking The strategy was effective to 📈GDMT  #ESCCongress @escardio @Rafavidalperez @BruiningNico @HFA_President @nature @WilfriedMullens @jozinetm @HanCardiomd @gcfmd @SJGreene_md @hvanspall @VDelgadoGarcia @CharlesFauvel @slumberbell

Challenges of aortic valve stenosis #VHD scenarios: how to get the diagnosis right with @EACVIPresident 🗓️Thursday, 16 October 2025, ⏲️ 18:00 to 19:00 CEST #Webinar Organiser: European Association of Cardiovascular Imaging (EACVI) Register now: 👉 https://t.co/Jr9L4KnQSj

🔥 New in @NatureMedicine How do you communicate lifetime benefits expected with HFpEF therapies? New data from 3 RCTs (#DELIVER #FINEARTS #PARAGON) estimate up to *5 years* of event-free survival w combination Rx #GDMT for HFpEF has finally arrived! 🔗 https://t.co/ozSx3UwkLN

Development of an Innovative Pipeline With Fusion, Digital Planning, and Three‐Dimensional Printing to Improve Mitral Valve Interventional Care - Man - 2025 - Echocardiography - Wiley Online Library https://t.co/DdwYZDIwTZ

Great work @ankeetbhatt !

📢 Results of our EASY-STOP study now presented #LBCT at #HeartFailure2025! A thread 🧵 1/ 🚀 First study to evaluate home-based #UNa using a POC sensor to guide loop diuretic downtitration in chronic #HeartFailure patients. #Cardiology #FOAMed

🚨 Excited to share our work on #AI #DASSi phenotyping of #AS on 2D #EchoFirst: a low-cost surrogate for multimodality imaging in AS trials A fun collaboration between @cards_lab @rohan_khera & @EdinburghUni (Marc Dweck, @neiljcraig et al) 🔗 Preprint + 🧵below #ACC25

For all the passionate professionals for cardiovascular imaging, this is your opportunity to mingle with, to network with and to learn from a large community with expertise on 4 modalities. Take advantage and join us! https://t.co/wTYVMtJOQV @iCorGTrias @imagen_sec

Proud to be part of this huge effort to synthesize the trial data with IV iron in HF with ID https://t.co/n0c0GwhzgH

Using #ArtificialIntelligence to calculate the heart’s biological age through #ECG data predicts increased risk of mortality and #cardiovascular events 👇 #AI #HeartHealth #EHRA2025 #EHRA_ESC

New from #ACC25: Dr. Nuccia Morici & colleagues report the results of ALTSHOCK-2, finding that early implantation of IABP does *not* reduce 60-day mortality in #heartfailure-related cardiogenic shock #JACC 🧵 (1/4)

Thrilled to share at #EHRA2025 the Choice-ICD study. An APP co-designed by patients @pumpinghearts @HFWarriorNI1 & clinical experts @BelfastTrust & GJNH, funded by @TheBHF. Ready to start UK testing @UlsterUniSoNP @QUBSONM

Would you discharge an eligible patient with HFrEF w/o one or more disease-modifying, life-saving medications? How about if you knew the odds are 7-15 fold against them ever being initiated as an outpatient? How about if you were contributing to 100K preventable ☠️s per year?

What is the likelihood that this RCT will meet its primary endpoint? A Digital Platform to Optimize Guideline Directed Heart Failure Therapy: Rationale and Design of the AIM-POWER Trial - Journal of Cardiac Failure https://t.co/F1tXnoEOHX @JCardFail @robmentz @texhern @HFSA

✅ When RCT protocol directed, a large proportion of patients with HFrEF are treated with quadruple GDMT ❌ In clinical practice, when left to clinician discretion, it is < 1 in 10 of patients eligible that are actually treated, even in settings with no cost/access barriers

HFmrEF/HFpEF can’t wait Rx the 3 🏛️ SGLTi + nsMRA + GLP-1 RA (if obesity) The optimal strategy is simultaneous or rapid sequence initiation to all eligible patients, without delay @gcfmd @JavedButler1 @DCRINews @JAMACardio https://t.co/OsmCRZXMcK…

The role of multi-modality imaging for the assessment of left atrium and #LAA: a clinical consensus statement of the @EACVIPresident & @EHRAPresident of @escardio by @EHJCVIEiC @leylaelifsade et al. ☑️ https://t.co/hAGbFTBQEV @denisamuraru @EHJIMPEiC @JGrapsa @BakhshiHooman

The clinical benefits of simultaneous or rapid initiation outweigh the potential risks in HFmrEF/HFpEF Simultaneous or Rapid Initiation of Combination Therapy for Heart Failure With Preserved Ejection Fraction https://t.co/wOXFw0ySnq @SJGreene_md @JavedButler1 @JAMACardio

What for Worsening Heart Failure Events https://t.co/bqZqnBsPzu @texhern @NMHheartdoc @JAMACardio @JavedButler1 @SJGreene_md @mvaduganathan @scottdsolomon @UoGHeartFailure

💡How to make #CVImaging research truly impact patient care? Raise the bar on precision & clinical relevance!🫀Check out the #EACVI statement🔗 https://t.co/EbiZt7Hzkx by💫 @denisamuraru @gpontone1 @RJurcut @JulienMagne @DonalErwan @Ivan_Echocardio @MariannaFonta11 @ElenaGalli10

Patients with suspected heart failure and elevated NT-proBNP in outpatient care had high mortality and morbidity in the weeks after presentation. Read the results of the REVOLUTION HF study just published in #EHJ 👉 https://t.co/TNfdcgcajL @RoccoMontone @ehj_ed #heartfailure